BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11861372)

  • 1. Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients.
    Li Z; Moore DH; Meng ZH; Ljung BM; Gray JW; Dairkee SH
    Cancer Res; 2002 Feb; 62(4):1000-3. PubMed ID: 11861372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite analysis of breast carcinoma and corresponding local recurrences.
    Regitnig P; Moser R; Thalhammer M; Luschin-Ebengreuth G; Ploner F; Papadi H; Tsybrovskyy O; Lax SF
    J Pathol; 2002 Oct; 198(2):190-7. PubMed ID: 12237878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancer.
    Hirano A; Emi M; Tsuneizumi M; Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2001 Apr; 7(4):876-82. PubMed ID: 11309336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer.
    Li Z; Meng ZH; Chandrasekaran R; Kuo WL; Collins CC; Gray JW; Dairkee SH
    Cancer Res; 2002 Apr; 62(7):1939-43. PubMed ID: 11929806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR; Singh B; Isaacs C; Dickson RB; Haddad BR
    Cancer Genet Cytogenet; 2004 Feb; 149(1):38-43. PubMed ID: 15104281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
    Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.
    Larson PS; Schlechter BL; de las Morenas A; Garber JE; Cupples LA; Rosenberg CL
    J Clin Oncol; 2005 Dec; 23(34):8613-9. PubMed ID: 16314623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoral angiolymphatic invasion and extensive intraductal component.
    Gaki V; Tsopanomichalou M; Sourvinos G; Tsiftsis D; Spandidos DA
    Eur J Surg Oncol; 2000 Aug; 26(5):455-60. PubMed ID: 11016465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast.
    Lakhani SR; Chaggar R; Davies S; Jones C; Collins N; Odel C; Stratton MR; O'Hare MJ
    J Pathol; 1999 Dec; 189(4):496-503. PubMed ID: 10629549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
    Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression.
    Li Z; Meng ZH; Sayeed A; Shalaby R; Ljung BM; Dairkee SH
    Cancer Res; 2002 Oct; 62(20):5980-7. PubMed ID: 12384566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
    Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location of several putative genes possibly involved in human breast cancer progression.
    Driouch K; Briffod M; Bièche I; Champème MH; Lidereau R
    Cancer Res; 1998 May; 58(10):2081-6. PubMed ID: 9605747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
    Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS
    Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.